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aBstract
Post-traumatic stress disorder (PTSD) is the most widespread mental illness 
resulting from exposure to combat, necessitating an increase in the provision of 
group therapy. This pilot study examined the efficacy of, and treatment outcome 
predictors associated with, group inpatient treatment of combat-related PTSD. 
Participants included 38 active duty military personnel deployed during Op-
eration Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF), diag-
nosed with PTSD, and consecutive admissions to an inpatient PTSD treatment 
facility. a paired samples t-test revealed significant change in symptom severity 
and global functioning between pre- and post-treatment. Multiple regression 
analyses supported the predictive utility of baseline symptomatology and group 
cohesion (> 50% of the variance in treatment outcome), highlighting the im-
portance of group cohesion in the efficacy of group treatment for combat-related 
PTSD.
according to the United States Department of Veterans Affairs
(VA) and the United States Department of Defense (DoD; U.S. 
Department of Veterans Affairs [VA/DoD], 2004), post-traumat-
ic stress disorder (PTSD) is the most common and widespread 
mental illness resulting from exposure to combat. PTSD impacts 
multiple domains of psychological and interpersonal function-
ing. According to Kessler (2000), people with PTSD are 1.5 times 
more likely to be unemployed than people without PTSD, and 
their chances of marital discord are increased by 60%. According 
to Gavlovski and Lyons (2003), the risk of suicide associated with 
PTSD exceeds that of any other anxiety disorder. Most of the re-
search into PTSD, especially combat-related PTSD, suggests that 
it is a chronic and debilitating disorder that is difficult to treat. A 
large-scale follow-up of combat veterans two years after receiving 
treatment for PTSD found that two-thirds of the population sur-
veyed had small to no improvement in s ymptoms (Creamer, El-
liott, Forbes, Biddle, & Hawthorne, 2006). Continued research is 
necessary to improve treatment outcomes and better understand 
combat-related PTSD.
According to Riddle and colleagues (2007), PTSD is currently 
the second most common clinical diagnosis in the military, affect-
ing 2.4% of the current millennium cohort. The U.S. Department 
of Veterans Affairs National Center for PTSD (2010) estimates 
between 6 and 11% of veterans from the conflicts in Afghanistan 
and 12% to 20% of veterans from the conflicts in Iraq have PTSD. 
Forbes and colleagues (2008) proposed, “optimizing treatment 
effectiveness through understanding factors that influence treat-
ment outcome, and tailoring interventions to presentation type, 
is critical” in working with combat-related PTSD (p. 142).
The VA currently provides two forms of evidence-based treat-
ments for PTSD, cognitive processing therapy (CPT; Resick, 
Monson, & Chard, 2008) and prolonged exposure therapy (PE; 
Hamblen, 2010). According to Freedberg (2008), the two tech-
niques have significant overlap, with CPT attempting to change 
the thought perceptions related to the traumatic experience and 
PE attempting to change the emotions related to the traumatic 
experience. Both have been shown to be effective in individual 
settings. With the exception of a few studies validating the origi-
nal feasibility and efficacy of CPT in group treatment settings, 
both models remain relatively untested in the context of group 
treatment, especially in the context of inpatient, group treatment 
of combat-related PTSD.
The VA-approved therapeutic interventions of CPT and PE are 
found to be effective in an individual therapy setting. However, 
the growing needs of the combat veteran community and the 
continuing conflicts in the Middle East will necessitate the use of 
group treatment for PTSD (Kingsley, 2007) due to the volume of 
service members needing treatment. There appears to be mini-
mal discussion in the literature about the facilitation of inpatient 
group treatment of combat veterans and active duty military and 
respective treatment outcomes. Group treatment is absent from 
the Va/DoD Clinical Practice Guideline for the Management of Post-
Traumatic Stress (VA/DoD, 2004). Given the increasing need for 
group treatment of combat veterans, the study of interventions 
and treatment outcomes in group settings is necessary for en-
hancing group treatment of combat-related PTSD. Group mod-
ules do exist for CPT; however, they require some editing of the 
construct in order to be administered in a group setting. One 
of the principal elements of the 12-step process of CPT is the 
trauma statement, in which a combat veteran is asked to describe 
in detail his or her experience that led to PTSD. According to 
nationally certified VA trainer, Amy Williams, Ph.D., it is recom-
mended that this aspect of CPT be omitted from group settings 
to reduce the effect of vicarious trauma—that is, providing ad-
ditional stress or triggering veterans who may have not had the 
same experience. As a result, use of CPT in a group setting tends 
to focus more on the impact of trauma (the ecological results of 
the traumatic experiences, such as not being able to trust oth-
ers, relationship conflict, etc.), rather than the specific traumatic 
experiences, which are given more focus in individual treatment.
The purpose of this study was (1) to examine the efficacy of 
CPT as a method of treating combat-related PTSD in a group, 
inpatient setting, and (2) to evaluate whether patient-specific 
predictor variables that have been known to impact individual 
treatment continue to impact treatment in a group setting, and 
if group cohesion serves as an additional predictor variable in 
the group inpatient treatment of combat-related PTSD. This pilot 
study offers a preliminary examination of these goals in a single, 
uncontrolled sample of active duty military participants receiv-
ing treatment in an inpatient setting.
To date, several studies have examined variables influencing 
treatment outcome in PTSD, such as baseline PTSD symptom-
atology (Karatzias et al., 2007), anger (Forbes et al., 2008), and 
personality factors (Forbes et al., 2002), among others. The ef-
fects of each of these factors have been measured in the context 
of individual therapy. However, few studies have examined the 
complex interplay of these factors and their effect on outcomes 
of group, inpatient treatment of combat-related PTSD.
In their study, Karatzias and colleagues (2007) found that base-
line PTSD symptomatology as assessed by the PTSD Symptom 
Checklist (PCL) was a significant treatment outcome predictor 
regardless of whether symptoms were assessed by a clinician 
(CAPS) or self-reported by patients using the Impact of Events 
Scale (IES) and the PCL. King and colleagues (2006) found that 
assessing the severity of combat itself (specific traumatic expe-
riences that occurred during combat), which is the primary fo-
cus of instruments like the PCL and CAPS, is not encompassing 
enough for addressing combat-related PTSD. Research by the Na-
tional Center for PTSD has found that stronger associations exist 
between post-combat experiences (e.g., body retrieval, providing 
medical attention to wounded comrades) and symptom severity 
in PTSD than with the actual severity of combat itself (King et 
al., 2006). However, the latter is the focus of most symptom mea-
sures. Therefore, it is important to measure the comprehensive 
experiences of deployment in addition to direct combat trauma 
in the assessment of baseline symptomatology in PTSD.
Personality factors associated with PTSD outcomes tend to 
concentrate more in the avoidance and arousal symptom clusters 
of PTSD. In their study of the impact of personality factors and 
mechanisms of anger on the outcome of PTSD treatment, Forbes 
and colleagues (2002) and Forbes and colleagues (2008) found 
that personality factors associated with social alienation and an-
ger at intake were predictive of change in PCL scores. The effects 
of anger are often comorbid with factors like alcohol use and 
amount of concern the veteran has about his or her experience of 
anger and its consequences, suggesting that anger may be an in-
dex factor for the amount of control a combat veteran feels over 
the environment and experience of symptoms. As a result, veter-
ans diagnosed with PTSD with personality factors associated with 
aggression and anger may fear losing control, and subsequently 
isolate themselves, in an effort to manage their symptoms. Per-
sonality factors associated specifically with social isolation, such 
as social detachment and social phobia, as measured by the Per-
sonality Assessment Inventory (PAI; Morey, 1991) also correlate 
with changes in symptom severity. 
According to research by Crowe and Grenyer (2008), subjective 
experiences of recovery reported by patients in group treatment 
settings appear to be associated more with the social functions 
of group therapy (e.g., being around others with similar experi-
ences, enhancing empathy, camaraderie), rather than individual 
therapist or modalities of treatment. Group treatment provides 
an opportunity to reduce the emotional isolation experienced by 
combat veterans by fostering a sense of cohesion between com-
mon cohort members, as evidenced by the report of veterans 
surveyed by Freedberg (2008). This suggests that in addition to 
the aforementioned patient-specific factors, group cohesion may 
prove to be a valuable aspect of assessment and important thera-
peutic goal
MEtHods
Participants
Participants consisted of a census of consecutive admissions to an 
inpatient program for the treatment of PTSD in combat veterans. 
Participants included 37 male and 1 female active duty military 
personnel who were veterans of Operation Enduring Freedom 
(OEF) and Operation Iraqi Freedom (OIF). PTSD diagnoses 
were confirmed by medical records, self-report symptom score 
at admission, and psychiatric verification of diagnosis. Criteria 
for inclusion in the study were the presence of combat exposure 
during the OEF and/or OIF conflicts combined with a PTSD di-
agnosis. All participants completed a minimum 28-day treatment 
protocol, including two to four hours of daily group therapy us-
ing a CPT model (Resick et al., 2008), a 12-step program for co-
occurring substance abuse/dependence (as appropriate), and 
additional milieu treatment. Therapists were licensed in the state 
and certified in training for CPT from a nationally accredited VA 
trainer. Demographic information obtained included age, mili-
tary branch, number of deployments, duration of deployments, 
marital status, number of children, custody arrangement, ethnic-
ity, and presence of chemical dependency.
Measures
A variety of self-report measures were used to assess effectiveness 
of treatment, baseline symptomatology, symptom improvement, 
and additional treatment predictor variables. These measures, 
listed below, assessed severity of combat exposure, global person-
ality factors, PTSD symptoms, social/interpersonal well-being, 
and aspects of group cohesion:
treatment Effectiveness
Treatment effectiveness was operationally defined as a clinically 
significant reduction in the severity of PTSD, as measured by the 
PTSD Checklist – Military Version (PCL-M; Weathers, Keane, & 
Davidson, 2001), and/or a statistically significant improvement 
in quality of life as measured by the Outcome Rating Scale (ORS; 
Duncan et al., 2003).
PCL-M. The PCL-M is a 17-item self-report measure of the 
Diagnostic and Statistical Manual of Mental Disorders, 4th edition 
(DSM-IV-TR; American Psychiatric Association, 2000), symptoms 
of PTSD for military personnel. The PCL has a high internal con-
sistency (α = .91–.96), and strong convergent validity (r = 0.79) 
with the CAPS (Keen, Kutter, Niles, & Krinsley, 2008). Clinical 
applications of the PCL-M have used cutoff scores ranging from 
50–60 as the baseline to establish clinical significance in a PTSD 
diagnosis (Keen et al., 2008). The clinical cutoff for this study was 
set as an average of the range, at 55.
ORS. The ORS is a 4-item visual analogue self-report outcome 
measure designed for tracking client progress in four interper-
sonal domains. Normative data for global functioning in a clini-
cal population using the ORS suggest an overall mean of 19.6 
(SD = 8.7) for the four subscales (Duncan et al., 2003), with a 
corresponding average of 4.9 (out of a 10-point Likert-type scale). 
The overall alpha for internal consistency on ORS administration 
is high (α = .97). Some studies have indicated that the test-retest 
reliability for the ORS is moderately high (r = .80 and .81, respec-
tively for one- to three-week retests; Bringhurst, Watson, Miller, & 
Duncan, 2006). The correlation between the Outcome Question-
naire 45.2 (OQ-45.2; Lambert et al., 1996) and the ORS is .59, 
indicating a moderate, but acceptable level of concurrent valid-
ity (Bringhurst et al., 2006). The ORS demonstrated construct 
validity by showing significantly different scores between treat-
ment and non-treatment populations (Miller, Duncan, Brown, 
Sparks, & Claud, 2003). In addition to demonstrating differences 
between clinical and non-clinical samples, construct validity was 
also shown by the differences in pre-treatment and post-treat-
ment patient scores (Miller et al., 2003). Based on a sample of 
35,000 patients and a clinical cut-off score of 25, Duncan and 
colleagues (2003) calculated a reliable change index (RCI), which 
and showed that a difference of 5 points between pre- and post-
scores demonstrated a clinically significant change.
Predictor Variables
Baseline symptomatology was assessed using the PCL-M, ORS, 
and Deployment Risk and Resilience Inventory (DRRI; U.S. De-
partment of Veterans Affairs National Center for PTSD [VA/
National Center], 2011) in an effort to identify comprehensive 
deployment variables that impact baseline symptom severity.
DRRI. The DRRI is a 203-item deployment experience self-
report measure comprised of yes/no and 5-point Likert-style 
questions designed by the National Centers for PTSD, as part 
of the VA, for research and descriptive purposes about personal 
history and deployment experiences. It contains 13 scales, rang-
ing from A: Pre-Deployment Life Events through encompassing 
combat and comprehensive deployment experiences to M: Post-
Deployment Life Events. Early psychometric assessment of the 
DRRI is encouraging, suggesting that it has promise for reliably 
assessing risk and resilience factors that contribute to veterans’ 
pre- and post-deployment well-being (King et al., 2006). The de-
velopmental foundations of the measure, specifically its factor 
analysis, allow for each of the measures in the DRRI to be used 
as a stand-alone instrument. No clinical cut-off scores exist for 
classifying clients into diagnostic groups, and clinical norms have 
not been yet established (VA/National Center, 2011).
PaI. Personality variables specific to aggression, anger, and so-
cial isolation were measured using the Personality Assessment 
Inventory (PAI; Morey, 1991), a 344-item self-report inventory 
that assesses various domains of personality and psychopathol-
ogy among adults. It was designed for use in professional and 
research settings. The PAI has a moderately high test-retest reli-
ability on the clinical scales (r = .79-.92; Morey, 1991).
CaLPaS-G. Group cohesion was measured using the Califor-
nia Psychotherapy Alliance Scale – Group Version (CALPAS-G; 
Gaston & Marmar, 1994). The CALPAS-G is a 12-item scale mea-
suring group cohesion in treatment through four subscales. The 
Patient Working Capacity Scale (PWC) assesses the patient’s will-
ingness to engage in group therapy as a result of the group’s dy-
namics. Patients rate their working capacity for each question on 
a Likert-style scale ranging from “0 – not at all” to “6 – very much 
so.” Gaston and Marmar (1993) define the PWC scale as “the 
group members’ ability or preparedness to self disclosure and 
self-reflect on salient therapy themes; to explore their contribu-
tion to problems; to experience strong emotions in a modulated 
fashion; to actively use therapist’s comments; to deepen explora-
tion of salient themes; and to purposefully work towards solving 
problems” (p. 5). The Patient Commitment Scale (PC) assesses 
the patient’s commitment to attending group and following 
through with group practice, the Working Strategy Consensus 
(WSC) scale assesses the patient’s sense of alignment with other 
group members and their common goals, and the Member Un-
derstanding and Involvement Scale (MUI) assesses the patient’s 
sense that other group members understand his or her specific 
experiences (Gaston & Marmar, 1994). The CALPAS-G has been 
shown to effectively assess group cohesion in previous studies 
(Crowe & Grenyer, 2008).
Procedure
Each participant was administered a battery of self-report mea-
sures upon admission to establish a baseline patient profile. This 
battery consisted of the DRRI, PAI, PCL-M, and ORS. During 
their inpatient stay, patients participated in a minimum of two 
hours of PTSD group therapy per day, as well as additional indi-
vidual therapy sessions with a unit therapist, milieu treatment, 
and group therapy addressing substance abuse if comorbid di-
agnosis was present. Upon termination of treatment, a PCL-M, 
ORS, and the CALPAS-G were administered. All measures were 
self-report, paper administered, and completed by the patients.
data analysis
The data were analyzed using SPSS Version 18.0. A paired sam-
ples t-test was performed comparing the means of baseline symp-
tomatology (PCL-M pre and ORS pre scores) with the means 
of symptomatology at terminus of treatment (PCL-M post and 
ORS post scores) to assess treatment efficacy. Pearson’s correla-
tion coefficients were used to test correlations between variables 
(demographics, PCL-M, ORS, PAI, and CALPAS-G). Multiple lin-
ear regression analyses were used to test the impact of predictor 
variables on treatment outcome (reduction in symptom severity 
on PCL-M, increase in interpersonal dimensions on ORS). Given 
that this was an exploratory pilot study and the n < 100, we did 
not run a large correlation matrix; rather, we ran bivariate analy-
ses based on our theoretical considerations (identified in previ-
ous research cited in the introduction). The significance level for 
this study was set at p < .05.
rEsults
Participant demographics
A total of 38 participants were included in this study (37 male, 1 
female). One participant dropped out due to leaving treatment 
for a family emergency and was omitted from analysis. Paramet-
ric participant demographics are detailed in Table 1. The major-
ity of participants were married (55.3%), followed by divorced 
(28.9%), single (7.9%), and separated (7.9%). Participants were 
employed by three branches of the U.S. Military: Army (92.1%), 
Air Force (5.3%), and Marine Corps (2.6%), and they consisted of 
enlisted (92.1%), officer (5.2%), and chief warrant officer (2.6%) 
ranks. Among participants, 13.2% were African American, 63.2% 
were Caucasian, 10.5% were Latino(a), 2.6% were Native Ameri-
can/Alaska Native, 2.6% of Arabic origin, and 7.9% were Pacific 
Islanders. All participants had a diagnosis of PTSD. A total of 
68.4% had an additional alcohol-related diagnosis, and 24.3% of 
participants (including those with alcohol-related diagnoses) also 
had an additional diagnosis of chemical dependency. 
descriptive statistics
Demographic variables did not correlate significantly with treat-
ment outcome as measured by the PCL post and ORS post scores 
in this study. Descriptive statistics for self-report measures are 
detailed in Table 2. In this study, the overall alpha for internal 
consistency on the PCL-M for the baseline score (α = 0.91) and 
final score (α = 0.96) were excellent (α > 0.90; Kline, 1999). The 
overall alpha for internal consistency on the ORS in this study 
ranged from good (α > 0.80; Kline, 1999) to excellent for the 
baseline score (α = 0.89) and final score (α = 0.96). The overall al-
pha for internal consistency on the CALPAS was good (α = 0.83). 
Consistent with previous research, these results show very strong 
reliability on all pre and post measures used in this study.
table 1. Mean, standard deviation, and Minimum 
and Maximum Values of demographics
demographic Variable M (SD) Min Max
Age 31 (6.81) 21 43
Number of Deployments 2.13 (1.34) 1 7
Number of Months Deployed 19.53 (10.02) 4 44
Number of Previous Marriages .55 (.72) 0 2
Number of Children 1.39 (1.33) 0 5
treatment outcome
A paired samples t-test showed a significant change between base-
line symptomatology at onset of treatment and symptom severity 
at terminus of treatment. The average PCL-M pre-treatment score 
table 2. Mean, standard deviation, and Minimum 
and Maximum Values for study Variables
scale M (SD) Min Max
Pre and Post symptomatology
PCL Pre 60.71 (13.703) 2.40 4.21
PCL Post 49.39 (18.72) 1.92 3.61
ORS Pre 13.56 (8.66) 3.05 3.68
ORS Post 24.98 (9.59) 5.68 6.68
Baseline symptomatology
DRRI A Scale (Pre Deployment Life Events) 5.05 (4.12) 0 14
DRRI I Scale (Combat Experiences) 11.16 (3.55) 2 15
DRRI J Scale (Post Battle Experiences) 11.79 (3.64) 0 15
DRRI L Scale (Post Deployment Support) 51.45 (10.38) 21 70
DRRI M Scale (Post Deployment Life Events) 4.86 (3.42) 0 1
Personality Factors
PAI ICN (Validity Scale – Inconsistency) 56.17 (12.59) 34 82
PAI INF (Validity Scale – Infrequency) 54.39 (10.86) 40 79
PAI NIM (Negative Impression Management) 73.47 (20.36) 44 122
PAI PIM (Positive Impression Management) 41.21 (9.53) 25 57
PAI SCZ S (Social Detachment) 67.89 (14.69) 43 97
PAI AGG A (Aggressive Attitude) 63.83 (16.38) 34 84
PAI AGG V (Verbal Aggression) 62.00 (13.03) 34 82
PAI AGG P (Physical Aggression) 73.42 (18.32) 42 103
PAI Total AGG (Aggression) 68.89 (17.27) 37 95
PAI ANT A (Antisocial Behaviors) 64.47 (13.60) 41 93
PAI ANT E (Egocentricity) 57.08 (12.10) 39 82
PAI ANT S (Stimulus Seeking) 68.44 (17.30) 40 103
PAI Total ANT (Antisocial) 66.71 (14.99) 40 98
PAI ALC (Alcohol Problems) 68.13 (21.21) 41 104
PAI DRG (Drug Problems) 64.18 (20.04) 42 112
PAI RXR (Treatment Rejection) 36.08 (7.27) 25 55
group cohesion
CALPAS PC (Patient Commitment) 14.16 (4.38) 0 18
CALPAS PWC (Patient Working Capacity) 12.54 (4.45) 4 18
CALPAS WSC (Working Strategy Consensus) 14.35 (3.22) 5 18
CALPAS MU (Member Understanding) 14.43 (2.89) 7 18
Note. All PAI scores are reported as t values. PTSD Checklist – Military Version (PCL-M), Outcome 
Rating Scale (ORS), Deployment Risk and Resilience Inventory (DRRI), Personality Assessment 
Inventory (PAI), California Psychotherapy Alliance Scale – Group Version (CALPAS-G).
(at baseline) was 60.71 (SD = 13.70). The average PCL-M post 
score was 49.39 (SD = 18.72). A comparison of means between 
PCL scores showed a significant reduction in reported symptom 
severity according to the criteria for PTSD diagnosis (paired t(37) 
= 4.6, p < .001). Effect size was medium-large (d = .601). The aver-
age ORS pre score (at baseline) was 13.56 (SD = 8.66). The aver-
age ORS post score was 24.98 (SD = 9.59). In addition to exceed-
ing the reliability change index of 5 points, the mean comparison 
between ORS scores also resulted in a statistically significant im-
provement in global functioning across interpersonal domains 
(paired t(37) = -8.185, p < .001). Effect size was medium (d = .560).
table 3. results of Pearson’s correlation analyses
Predictor Variable
Pcl-M Post 
correlation
ors Post 
correlation
Baseline symptomatology
PCL-M Pre Score .60** -.26
ORS Pre Score -.42** .56**
DRRI Pre Deployment Life Events (A) -.08 -.03
DRRI Combat Experiences (I) .21 -.20
DRRI Post Battle Experiences (J) .22 -.08
DRRI Post Deployment Support (L) -.24 .36**
DRRI Post Deployment Life Events (M) .19 -.20
Personality Factors (Pai)
Neg Impression Mgmt (NIM) .43** -.39*
Pos Impression Mgmt (PIM) -.13 .13
Social Detachment (SCZ-S) .56** -.46**
Antisocial (ANT) .05 -.14
Aggressive Attitude (AGG-A) .38* -.25
group cohesion (calPas-g)
Patient Commitment (PC) -.15 .22
Patient Working Capacity (PWC) -.58**  .41*
Working Strategy Consensus (WSC) -.064 .27
Member Understanding (MU) -.09 .37*
Note. *Significant at the 0.05 level (2-tailed); **significant at the 0.01 level (2-tailed). PTSD Checklist 
– Military Version (PCL-M), Outcome Rating Scale (ORS), Deployment Risk and Resilience Inventory 
(DRRI), Personality Assessment Inventory (PAI), California Psychotherapy Alliance Scale – Group 
Version (CALPAS-G).
correlation and regression statistics
Consistent with previous research, several predictor variables 
correlated with treatment outcomes. Effect sizes ranged from 
moderate (r > .30) to large (r > .50). These results are detailed 
in Table 3. Analyses did not reveal any measures of association 
between demographic and outcome variables. The strongest cor-
relations were found between baseline symptomatology as mea-
sured by the PCL-M pre score and PCL-M post score (r(36) = .601, 
p < .001), global functioning, as measured by the ORS pre and 
ORS post (r(36) = .560, p < .001), the personality factor of social 
detachment (PAI SCZ-S) and PCL-M post score (r(34) = .560, p < 
.000), and the group cohesion measure of PWC and PCL-M post 
score (r(36) = -.580, p < .001).
Linear regression analyses to predict the PCL-M post score (at 
discharge) were performed in forward stepwise analysis. When 
both predictors were entered into the equation, a significant re-
gression equation was found (F(2,34) = 19.372, p < .000) with an 
R2 of .533, with predictors accounting for 53.9% of the variance 
in PCL-M post scores (PCL-Pre (R2 = .337) and PWC (R2 = .202). 
Coefficients for the predictor variables included PCL-M pre score 
(β =.46, t = 3.77, p < .001) and PWC (β =-.454, t = -3.72, p < .001). 
Linear regression analyses to predict the ORS post score (at 
discharge) were performed in forward stepwise analysis. When 
both predictors were entered into the equation, results were con-
sistent with previous regression analysis and resulted in a signifi-
cant regression equation showing that ORS pre score (F(1,33) β = 
12.51, p = .001) and PWC (F(2,32) = 9.24, p = .001) predicted ORS 
post score, but that the other variables detailed in Table 3 did 
not. Predictors accounted for 36.6% of the variance (R2 = .366; 
ORS-Pre R2 = .275; PWC R2 = .091).
additional analyses
The significant results showing the ability of the PWC subscale 
of the CALPAS-G to predict treatment outcome, in addition to 
baseline symptomatology, led to additional analysis to determine 
the strength of the association of these subscale items. The three 
items of the PWC scale all correlated significantly with treatment 
outcome as measured by the PCL post score. These items were: 
(2) “When important things come to mind, how often did you 
find yourself keeping them to yourself rather than sharing them 
with the group”; (4) “How much did you hold back your feelings 
during the group therapy process”; and (11) “Did you have the 
impression that you were unable to deepen your understanding 
of what was bothering you?” Results of additional Pearson’s cor-
relational analyses are detailed in Table 4.
discussioN
The results of this pilot study suggest that inpatient group treat-
ment for active duty military personnel significantly improved 
patients’ perceptions of their overall functioning and significant-
ly reduced their experience of symptoms associated with PTSD. 
When PCL-M post score was used as a treatment outcome mea-
suring reduction in PTSD-specific symptoms, PCL-Pre and PWC 
accounted for 53.9% of the variance in outcome and demonstrat-
ing moderate effect size. Baseline symptomatology, as measured 
by the PCL-M, baseline global functioning, as measured by the 
ORS, and the PWC subscale of the group cohesion measure were 
found to be significant predictors of positive treatment outcomes 
(reduction in symptom severity and improvement in global func-
tioning). These clinically significant results support two of the 
principal hypotheses of this study: that (1) treatment of PTSD 
using CPT in a group inpatient treatment setting is effective, and 
(2) baseline symptomatology (including global functioning) and 
group cohesion could significantly predict treatment outcome for 
military personnel receiving treatment for combat-related PTSD 
in a group, inpatient setting. The relationship between symptom 
severity and treatment outcome is meaningful because it extends 
the previous research regarding the predictive utility of symp-
table 4. results of Pearson’s correlation analyses for PWc items
calPas PWc item Pcl-M Post correlation
Question 2 (keeping thoughts to yourself) .60*
Question 4 (Holding back feelings) .38**
Question 11 (Unable to deepen understanding) .40**
Note. *Significant at the 0.05 level (2-tailed); **significant at the 0.01 level (2-tailed).
tom severity to the treatment venue of a group setting (Karatzias 
et al., 2007). The relationship between PWC and treatment out-
come suggests that, consistent with Crowe and Grenyer’s (2008) 
research, the patient’s willingness to engage in the group process 
due to the nature of the group itself and to share and process per-
sonal information in a group setting are the functional aspects of 
treatment of combat-related PTSD in a group setting. 
Given that group modalities are the wave of the future for the 
treatment of PTSD in combat veterans (Kingsley, 2007), it is im-
portant to know that a variable not relevant to individual treat-
ment modalities—the capacity to work with others in the context 
of a group—is a significant and unique predictor of treatment 
outcome. This study suggests that group treatment for PTSD is 
effective and may control for other factors that have been shown 
to affect outcomes in individual treatment. This effect may be 
moderated by the patient’s willingness to engage in the group 
process and share personal information in the setting; that is, the 
suggested effectiveness of group treatment appears to be signifi-
cantly related to a patient’s willingness to engage in the particular 
group treatment context. Group modalities of treatment should 
foster healthy settings in which patients can engage in group 
sharing and group process. Patients should be assessed for their 
working capacity at the onset of treatment, and hesitations they 
have about sharing in group should be addressed to encourage 
this aspect of group cohesion.
These findings need to be considered in light of limitations 
associated with this study. The sample for this study was small, 
with limited statistical power. Given the nature of the treatment 
setting, it is difficult to separate the effects of the various aspects 
of multidisciplinary treatment (e.g., milieu, 12-step, psychophar-
macological interventions) that participants received in addition 
to their regular CPT groups. The study is from one inpatient 
treatment setting that utilized CPT, and results may not be gen-
eralized to other treatment facilities. Results are from a predomi-
nantly male population, and a control group was not utilized. 
Despite the aforementioned limitations, results from this study 
support the theory that patient willingness to engage in treat-
ment and be vulnerable in group settings and the facilitation of 
this working capacity offered by the group are essential aspects 
of the group treatment of PTSD. Findings suggest that focusing 
solely on individual aspects of participants, such as personality 
and demographics, is insufficient for group treatment of PTSD. 
Also, when baseline symptomatology is combined with a factor 
of group cohesion, more than 50% of the variance of treatment 
outcome is accounted for, suggesting that group treatment is an 
effective method for the treatment of PTSD.
Where this research supports an aspect of group cohesion as 
a treatment outcome predictor, it does not identify factors that 
enhance or inhibit the patient working capacity factor of group 
cohesion. Future research may benefit from assessing aspects of 
group treatment that increase the patient working capacity fac-
tor of group cohesion, therefore enhancing treatment efficacy. It 
would be beneficial to have patients identify their perceived bar-
riers to “self disclose and self-reflect on salient therapy themes” 
(Gaston & Marmar, 1993, p. 5) in group treatment settings. Once 
factors that enhance and inhibit this particular outcome predictor 
are established, treatment programs may develop protocols and 
progressive group ethos to address these factors. Future research 
should also include the assessment of multiple populations, in-
cluding more female participants, increased ethnic diversity, and 
in multiple group settings, such as outpatient and day treatment 
programs.
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